Derace Schaffer
Diagnostic Radiology Rochester, NY Medical Doctor
NPI 1750623328 CMS profile 925891
2263 Clinton Ave S, Rochester, NY 14618
General payments
$2,135,526
Research payments
$0
Ownership & investment interest
$38,548,339
Through program year 2025, Derace Schaffer of Rochester, NY is reported in the CMS Open Payments database as having received $2,135,526 across 103 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $38,548,339 across 9 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
12 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,249,079 | 39 | |
| 2024 | General | $661,436 | 27 | |
| 2022 | General | $528 | 1 | |
| 2020 | General | $157,442 | 9 | |
| 2019 | General | $67,042 | 27 | |
| 2025 | Ownership | $6,346,262 | 1 | |
| 2024 | Ownership | $5,518,712 | 1 | |
| 2023 | Ownership | $4,883,128 | 1 | |
| 2022 | Ownership | $6,964,532 | 1 | |
| 2021 | Ownership | $6,200,217 | 1 | |
| 2020 | Ownership | $4,468,909 | 2 | |
| 2019 | Ownership | $4,166,578 | 2 |
Beside peers
- Derace Schaffer
- Diagnostic Radiology median
- Middle half of Diagnostic Radiology
- National median
In program year 2025, general payments to Derace Schaffer were reported at $1,249,079. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.
Show as a table
| Year | Derace Schaffer | Diagnostic Radiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $67,042 | $108 | $29–$318 | $163 |
| 2020 | $157,442 | $65 | $21–$252 | $114 |
| 2021 | $0 | $92 | $24–$292 | $132 |
| 2022 | $528 | $104 | $29–$294 | $149 |
| 2023 | $0 | $110 | $29–$337 | $160 |
| 2024 | $661,436 | $113 | $30–$356 | $164 |
| 2025 | $1,249,079 | $112 | $32–$349 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
103 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Diagnostic Radiology in New York
Thomas Sos
Diagnostic Radiology · New York, NY
Lawrence Tanenbaum
Diagnostic Radiology · New York, NY
Alan Brook
Diagnostic Radiology · Bronx, NY
Jason Dunleavy
Diagnostic Radiology · Williamsville, NY
Gregory Sica
Diagnostic Radiology · New York, NY
Kevin Baker
Diagnostic Radiology · Stony Brook, NY
Related records
Diagnostic Radiology in New York
Practitioners in the same specialty and state, ranked by reported value.
All Diagnostic Radiology
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.